DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Blay JY, Shen L, Kang YK.
Phase III trial of nilotinib versus imatinib as first-line targeted therapy of advanced gastrointestinal stromal tumors (GIST).
J Clin Oncol 2013;
31 (Suppl. 01) abstr 10501
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.